News
The FDA's approval of the first CRISPR-Cas9–based gene therapy marked a major milestone in biomedicine, validating genome ...
Scientists in Japan have used CRISPR gene-editing technology to remove the extra chromosome that causes Down syndrome.
Global Cell and Gene Therapy Market to Grow at 23% CAGR Driven by R&D and Regulatory Support by 2030
The global cell and gene therapy market is experiencing significant expansion, driven by rising approvals and advancements in ...
6h
News-Medical.Net on MSNCRISPR screening uncovers microproteins involved in fat storageThe obesity rate has more than doubled in the last 30 years, affecting more than one billion people worldwide.
21hon MSN
Complex structure of humans eyes found to be similar to those of freshwater apple snail, which can entirely regenerate its ...
These decisions affect not just the archetypal Ivy League student many imagine—they affect people who grew up in places like ...
22h
AZoLifeSciences on MSNParkinson’s Gene Mutation Blocks Vital Neuroprotective SignalsGBA1 mutations impair ciliary Hedgehog signaling in Parkinson's disease, reducing neuroprotective factors and highlighting a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results